Y-Prime Technologies Expands Into Europe And Names Jeanette Anne Greef As Senior Business Analyst

Y-Prime Technologies LLC, a premier eClinical products and life sciences consulting services company, has expanded its international operations in Europe and has named Jeanette Anne Greef as senior business analyst in the U.K. office.

Greef has more than 15 years of experience in leadership and management experience within the pharmaceutical industry (regulatory and clinical operations environments) as well as the U.K. health service.  

"Y-Prime offers a broad suite of consulting services and solutions that streamline operations as well as increase efficiency and compliance, which is of significant value to global pharmaceutical companies," explains Dave Espenshade, senior vice president of sales and marketing.  "Jeanette has terrific experience and will be a significant asset helping to expand our international client penetration of eClinical products and consulting services.

Prior to joining Y-Prime, Greef held various management positions at Medimmune LLC.   From 2009-2011, Greef served as director of regulatory and clinical services for Liquent, with full responsibility for all regulatory operation functions in Europe and India.  During her career, she has also held a variety of management positions at TKT/Shire Human Genetic Therapies, Welwen Garden City and Amgen Ltd.

She attended the University of Northumbria, Newcastle where she earned her post graduate certification with distinction in records management in 2006. Greef earned her certification in Information Technology from Huntingdonshire Technical College.

About Y-Prime

Y-Prime Technologies LLC is a premier eClinical products and consulting company that leverages groundbreaking platform technology and systems intelligence to provide novel, personalized decision making solutions to life sciences companies.  Since 2006, Y-Prime has developed a robust franchise of enterprise, clinical and operations solutions that offer the potential to dramatically accelerate time to market while significantly reducing costs.  For more information please visit www.y-prime.com.